ZIOPHARM ONCOLOGY (NASDAQ:ZIOP)

3.88

0.07 (1.77%)

ZIOPHARM ONCOLOGY (NASDAQ:ZIOP) Delayed :
Previous Close	$3.95	52 Week High	$4.10
Open	$3.94	52 Week Low	$0.50
Day High	$4.00	P/E	N/A
Day Low	$3.72	EPS	$-0.62
Volume	138,130
More ZIOP Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
JADE	2	UCBH	2
ACPW	2	UPI	2
CHIO	2	CNO	2
HANS	1	TASR	1
ARP	1	LGND	1
UCBH	1	WG	1

View All Entities

Nov 11, 2009 07:43 AM ZIOPHARM Oncology (ZIOP) Posts Q3 Loss of $0.13, Better Y/Y

Nov 11, 2009 07:43 AM ZIOPHARM Oncology (ZIOP) Posts Q3 Loss of $0.13, Better Y/Y
Nov 6, 2009 10:47 AM Morning Movers 11/06: ACLS, CVM, ZIOP, LPSN, CABL, ZGEN Higher; NHWK, GOK, CROX, CVI, RAIL, CSTR Lower
Oct 14, 2009 01:52 PM Unusual 11 Mid-Day Movers 10/14: CHIO, ACPW, JADE, CNO Higher; CXM, HILL, UCBH, UPI Lower
Oct 14, 2009 09:50 AM Morning Movers 10/14: ACPW, CNO, ZIOP, CHIO, JADE Higher; UPI, UCBH Lower
Oct 14, 2009 09:09 AM ZIOPHARM (ZIOP) Reports Positive Palifosfamide Sarcoma Phase II Data; Will Initiate Registration

Nov 11, 2009 07:40AM ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress
Nov 9, 2009 08:35AM ZIOPHARM to Host Analyst & Institutional Investor Meeting on November 19, 2009
Nov 6, 2009 07:13AM ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
Nov 3, 2009 08:40AM ZIOPHARM Oncology to Present at the Merriman, Curhan, Ford Investor Summit 2009
Oct 22, 2009 08:40AM -- ZIOPHARM Oncology to Present at the 8th Annual BIO Investor Forum --

Nov 9, 2009 04:58 AM Ziopharm Oncology: Step by Step
Nov 6, 2009 04:15 PM Closing Bell: Unemployment must not be relevant (GE, ACOM, FNM, ZIOP, MOT, NVDA)
Oct 14, 2009 12:09 PM BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics
Aug 4, 2009 09:17 AM Ziopharm Oncology: Deal or Dilution?
Sep 24, 2007 11:00 AM Analyst initiations: VMW, VR and HOLX

No comments are currently available.